The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.
Computational pharmaceutics - A new paradigm of drug delivery
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
LeCun, Y., Bengio, Y., & Hinton, G. (2015) · Nature · doi:10.1038/nature14539 · Cited by 84,126
Highly accurate protein structure prediction with AlphaFold
Jumper, J., Evans, R., Pritzel, A., Green, T., Figurnov, M., Ronneberger, O., Tunyasuvunakool, K., Bates, R., Žídek, A., Potapenko, A., et al. (2021) · Nature · doi:10.1038/s41586-021-03819-2 · Cited by 43,764
Chemistry and Properties of Nanocrystals of Different Shapes
Burda, C., Chen, X., Narayanan, R., & El-Sayed, M. A. (2005) · Chemical Reviews · doi:10.1021/cr030063a · Cited by 7,230
Doxil® — The first FDA-approved nano-drug: Lessons learned
Barenholz, Y. (. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.03.020 · Cited by 4,792
Innovation in the pharmaceutical industry: New estimates of R&D costs
DiMasi, J. A., Grabowski, H. G., & Hansen, R. W. (2016) · Journal of Health Economics · doi:10.1016/j.jhealeco.2016.01.012 · Cited by 3,359
Coarse Grained Model for Semiquantitative Lipid Simulations
Marrink, S. J., de Vries, A. H., & Mark, A. E. (2004) · The Journal of Physical Chemistry B · doi:10.1021/jp036508g · Cited by 2,257
Diagnosing the decline in pharmaceutical R&D efficiency
Scannell, J. W., Blanckley, A., Boldon, H., & Warrington, B. (2012) · Nature Reviews Drug Discovery · doi:10.1038/nrd3681 · Cited by 1,981
Sheller, M. J., Edwards, B., Reina, G. A., Martin, J., Pati, S., Kotrotsou, A., Milchenko, M., Xu, W., Marcus, D., Colen, R. R., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-69250-1 · Cited by 1,646
Burger, B., Maffettone, P. M., Gusev, V. V., Aitchison, C. M., Bai, Y., Wang, X., Li, X., Alston, B. M., Li, B., Clowes, R., et al. (2020) · Nature · doi:10.1038/s41586-020-2442-2 · Cited by 1,516
Wu, C.-Y., & Benet, L. Z. (2005) · Pharmaceutical Research · doi:10.1007/s11095-004-9004-4 · Cited by 1,401
Research works printed but not linked: 171
- Chong, 2007, New uses for old drugs, Nature, 448, 645, 10.1038/448645a · DOI · Paper page
- Beg, 2011, Bioavailability enhancement strategies: basics, formulation approaches and regulatory considerations, Curr. Drug Deliv., 8, 691, 10.2174/156720111797635504 · doi:10.2174/156720111797635504
- Park, 2015, Drug delivery of the future: Chasing the invisible gorilla, J. Control. Release, 240, 2
- Kinam, 2014, Controlled drug delivery systems: Past forward and future back, J. Control. Release, 190, 3, 10.1016/j.jconrel.2014.03.054 · DOI · Paper page
- Barratt, 2011, Takeru Higuchi, the man and the scientist, Int. J. Pharm., 418, 3, 10.1016/j.ijpharm.2011.05.019 · doi:10.1016/j.ijpharm.2011.05.019
- Clark, 2015, Medical aerosol inhalers: past, present, and future, Aerosol Sci. Technol., 22, 374, 10.1080/02786829408959755 · DOI
- Pastore, 2015, Transdermal patches: history, development and pharmacology, Br. J. Pharmacol., 172, 2179, 10.1111/bph.13059 · DOI · Paper page
- Yun, 2015, Controlled drug delivery: historical perspective for the next generation, J. Control. Release, 219, 2, 10.1016/j.jconrel.2015.10.005 · DOI · Paper page
- Miele, 2009, Albumin-bound formulation of paclitaxel (Abraxane® ABI-007) in the treatment of breast cancer, Int. J. Nanomedicine, 4, 99
- Park, 2019, The beginning of the end of the nanomedicine hype, J. Control. Release, 305, 221, 10.1016/j.jconrel.2019.05.044 · DOI · Paper page
- Nakamura, 2016, Nanodrug delivery: is the enhanced permeability and retention effect sufficient for curing cancer?, Bioconjug. Chem., 27, 2225, 10.1021/acs.bioconjchem.6b00437 · DOI · Paper page
- Rowe, 1998, Artificial intelligence in pharmaceutical product formulation: Knowledge-based and expert systems, Pharm. Sci. Technol. Today, 1, 153, 10.1016/S1461-5347(98)00042-X · doi:10.1016/s1461-5347(98)00042-x
- Yu, 2014, Understanding pharmaceutical quality by design, AAPS J., 16, 771, 10.1208/s12248-014-9598-3 · DOI · Paper page
- Yu, 2019, FDA's new pharmaceutical quality initiative: knowledge-aided assessment & structured applications, Int. J. Pharm. X, 1, 100010
- Zhao, 2019, Generating model integrated evidence for generic drug development and assessment, Clin. Pharmacol. Ther., 105, 338, 10.1002/cpt.1282 · DOI
- Marshall, 2019, Model-informed drug discovery and development: current industry good practice and regulatory expectations and future perspectives, CPT Pharmacometrics Syst. Pharmacol., 8, 87, 10.1002/psp4.12372 · DOI · Paper page
- Sato, 2017, Quantitative modeling and simulation in PMDA: a Japanese regulatory perspective, CPT Pharmacometrics Syst. Pharmacol., 6, 413, 10.1002/psp4.12203 · DOI
- 2009, 74(109), 27325
- Schuhmacher, 2020, The upside of being a digital pharma player, Drug Discov. Today, 10.1016/j.drudis.2020.06.002 · DOI
- Schuhmacher, 2019, The Art of Virtualizing Pharma R&D, Drug Discov. Today, 24, 2105, 10.1016/j.drudis.2019.07.004 · DOI
- Hussain, 1991, Application of neural computing in pharmaceutical product development, Pharm. Res., 8, 1248, 10.1023/A:1015843527138 · DOI
- Erb, 1993, Introduction to backpropagation neural network computation, Pharm. Res., 10, 165, 10.1023/A:1018966222807 · DOI · Paper page
- Rowe, 1998, Artificial intelligence in pharmaceutical product formulation: Neural computing and emerging technologies, Pharm. Sci. Technol. Today, 1, 200, 10.1016/S1461-5347(98)00055-8 · DOI
- Takayama, 1999, Artificial neural network as a novel method to optimize pharmaceutical formulations, Pharm. Res., 16, 1, 10.1023/A:1011986823850 · DOI
- Sun, 2003, Application of artificial neural networks in the design of controlled release drug delivery systems, Adv. Drug Deliv. Rev., 55, 1201, 10.1016/S0169-409X(03)00119-4 · DOI · Paper page
- Takayama, 2003, Neural network based optimization of drug formulations, Adv. Drug Deliv. Rev., 55, 1217, 10.1016/S0169-409X(03)00120-0 · DOI
- Ekins, 2006, Application of data mining approaches to drug delivery, Adv. Drug Deliv. Rev., 58, 1409, 10.1016/j.addr.2006.09.005 · DOI
- Colbourn, 2009, Novel approaches to neural and evolutionary computing in pharmaceutical formulation: Challenges and new possibilities, Future Med. Chem., 1, 713, 10.4155/fmc.09.57 · doi:10.4155/fmc.09.57
- Ibrić, 2012, Artificial neural networks in evaluation and optimization of modified release solid dosage forms, Pharmaceutics, 4, 531, 10.3390/pharmaceutics4040531 · DOI
- Dai, 2019, SeDeM expert system for directly compressed tablet formulation: A review and new perspectives, Powder Technol., 342, 517, 10.1016/j.powtec.2018.10.027 · doi:10.1016/j.powtec.2018.10.027
- Zhang, 2011, Design of an expert system for the development and formulation of push-pull osmotic pump tablets containing poorly water-soluble drugs, Int. J. Pharm., 410, 41, 10.1016/j.ijpharm.2011.03.013 · doi:10.1016/j.ijpharm.2011.03.013
- Hamman, 2018, Development of multiple-unit pellet system tablets by employing the SeDeM expert diagram system I: pellets with different sizes, Pharm. Dev. Technol., 23, 706, 10.1080/10837450.2017.1342657 · doi:10.1080/10837450.2017.1342657
- Hamman, 2019, Development of multiple-unit pellet system tablets by employing the SeDeM expert diagram system II: pellets containing different active pharmaceutical ingredients, Pharm. Dev. Technol., 24, 145, 10.1080/10837450.2018.1435691 · doi:10.1080/10837450.2018.1435691
- Aguilar-Díaz, 2012, Predicting orally disintegrating tablets formulations of ibuprophen tablets: an application of the new SeDeM-ODT expert system, Eur. J. Pharm. Biopharm., 80, 638, 10.1016/j.ejpb.2011.12.012 · doi:10.1016/j.ejpb.2011.12.012
- Wang, 2021, PharmDE: a new expert system for drug-excipient compatibility evaluation, Int. J. Pharm., 120962, 10.1016/j.ijpharm.2021.120962 · DOI
- Han, 2019, Predicting physical stability of solid dispersions by machine learning techniques, J. Control. Release, 311-312, 16, 10.1016/j.jconrel.2019.08.030 · DOI · Paper page
- Gao, 2021, An integrated computational methodology with data-driven machine learning, molecular modeling and PBPK modeling to accelerate solid dispersion formulation design, Eur. J. Pharm. Biopharm., 158, 336, 10.1016/j.ejpb.2020.12.001 · DOI
- Zhao, 2019, Predicting complexation performance between cyclodextrins and guest molecules by integrated machine learning and molecular modeling techniques, Acta Pharm. Sin. B, 9, 1241, 10.1016/j.apsb.2019.04.004 · DOI
- He, 2020, Can machine learning predict drug nanocrystals?, J. Control. Release, 322, 274, 10.1016/j.jconrel.2020.03.043 · DOI
- Gao, 2021, Integrated in silico formulation design of self-emulsifying drug delivery systems, Acta Pharm. Sin. B
- Ye, 2019, An integrated transfer learning and multitask learning approach for pharmacokinetic parameter prediction, Mol. Pharm., 16, 533, 10.1021/acs.molpharmaceut.8b00816 · DOI
- Ye, Z., et al., Interpretable Machine Learning Methods for In Vitro Pharmaceutical Formulation Development. 2021. 2(2): p. 195–207.DOI: doi:https://doi.org/10.1002/fft2.78. · DOI
- Tang, 2021, GANDA: A deep generative adversarial network conditionally generates intratumoral nanoparticles distribution pixels-to-pixels, J. Control. Release, 336, 336, 10.1016/j.jconrel.2021.06.039 · DOI
- Silva-Júnior, 2017, Quantum Mechanical (QM) Calculations Applied to ADMET Drug Prediction: A Review, Curr. Drug Metab., 18, 511, 10.2174/1389200218666170316094514 · doi:10.2174/1389200218666170316094514
- Sibambo, 2007, Elucidation of the physicomechanical and ab initio quantum energy transitions of a crosslinked PLGA scaffold, Biomaterials, 28, 3714, 10.1016/j.biomaterials.2007.04.045 · DOI
- Abramov, 2020, Guiding lead optimization for solubility improvement with physics-based modeling, Mol. Pharm., 10.1021/acs.molpharmaceut.9b01138 · doi:10.1021/acs.molpharmaceut.9b01138
- Klimeš, 2010, Chemical accuracy for the van der Waals density functional, J. Phys. Condens. Matter, 22(2)
- MacKerell, 1998, All-atom empirical potential for molecular modeling and dynamics studies of proteins, J. Phys. Chem. B, 102, 3586, 10.1021/jp973084f · DOI · Paper page
- Chan, 2018, Investigating the molecular dissolution process of binary solid dispersions by molecular dynamics simulations, Asian J. Pharmaceutical Sci., 13, 248
- Leuner, 2000, Improving drug solubility for oral delivery using solid dispersions, Eur. J. Pharm. Biopharm., 50, 47, 10.1016/S0939-6411(00)00076-X · DOI · Paper page
- Ouyang, 2012, Investigating the molecular structures of solid dispersions by the simulated annealing method, Chem. Phys. Lett., 554, 177, 10.1016/j.cplett.2012.10.056 · DOI
- Floresta, 2019, Supramolecular host-guest interactions of pseudoginsenoside F11 with β- and γ-cyclodextrin: Spectroscopic/spectrometric and computational studies, J. Mol. Struct., 1195, 387, 10.1016/j.molstruc.2019.05.134 · doi:10.1016/j.molstruc.2019.05.134
- Sun, 2018, Mechanism and structure studies of cinnamaldehyde/cyclodextrins inclusions by computer simulation and NMR technology, Carbohydr. Polym., 194, 294, 10.1016/j.carbpol.2018.04.055 · doi:10.1016/j.carbpol.2018.04.055
- Mokhtar, 2019, Atrazine and ametryne inclusion complexes with 2-hydroxypropyl-β/γ-cyclodextrin: Spectroscopic studies and molecular dynamics simulation, J. Mol. Struct., 1179, 161, 10.1016/j.molstruc.2018.11.002 · DOI
- Mokhtar, 2018, Experimental and molecular modeling investigations of inclusion complexes of imazapyr with 2-hydroxypropyl(β/γ) cyclodextrin, J. Mol. Liq., 262, 504, 10.1016/j.molliq.2018.04.088 · doi:10.1016/j.molliq.2018.04.088
- Yasuda, 2019, Molecular dynamics of polyrotaxane in solution investigated by Quasi-elastic neutron scattering and molecular dynamics simulation: sliding motion of rings on polymer, J. Am. Chem. Soc., 141, 9655, 10.1021/jacs.9b03792 · doi:10.1021/jacs.9b03792
- Medarević, 2015, Influence of hydrophilic polymers on the complexation of carbamazepine with hydroxypropyl-β-cyclodextrin, Eur. J. Pharm. Sci., 78, 273, 10.1016/j.ejps.2015.08.001 · DOI
- Alvira, 2019, Molecular simulation of the separation of isoleucine enantiomers by β-Cyclodextrin, Molecules, 24, 1021, 10.3390/molecules24061021 · doi:10.3390/molecules24061021
- Alvira, 2017, Influence of solvent polarity on the separation of leucine enantiomers by β-cyclodextrin: a molecular mechanics and dynamics simulation, Tetrahedron Asymmetry, 28, 1414, 10.1016/j.tetasy.2017.09.020 · doi:10.1016/j.tetasy.2017.09.020
- Zhao, 2018, Computer-aided formulation design for a highly soluble lutein–cyclodextrin multiple-component delivery system, Mol. Pharm., 15, 1664, 10.1021/acs.molpharmaceut.8b00056 · doi:10.1021/acs.molpharmaceut.8b00056
- Gao, 2021, Integrated computer-aided formulation design: a case study of andrographolide/cyclodextrin ternary formulation, Asian J. Pharmaceutical Sci.
- Ntountaniotis, 2019, Host–Guest interactions between candesartan and its prodrug candesartan cilexetil in complex with 2-Hydroxypropyl-β-cyclodextrin: on the biological potency for angiotensin II antagonism, Mol. Pharm., 16, 1255, 10.1021/acs.molpharmaceut.8b01212 · doi:10.1021/acs.molpharmaceut.8b01212
- Ouyang, 2010, Structure, dynamics, and energetics of siRNA−Cationic vector complexation: a molecular dynamics study, J. Phys. Chem. B, 114, 9220, 10.1021/jp911906e · DOI
- Ouyang, 2010, Structure and dynamics of multiple cationic vectors−siRNA complexation by all-atomic molecular dynamics simulations, J. Phys. Chem. B, 114, 9231, 10.1021/jp911913c · doi:10.1021/jp911913c
- Sun, 2013, A molecular dynamics simulation study on the effect of lipid substitution on polyethylenimine mediated siRNA complexation, Biomaterials, 34, 2822, 10.1016/j.biomaterials.2013.01.011 · doi:10.1016/j.biomaterials.2013.01.011
- Monpara, 2019, Cationic cholesterol derivative efficiently delivers the genes: in silico and in vitro studies, Drug Deliv. Transl. Res., 9, 106, 10.1007/s13346-018-0571-z · doi:10.1007/s13346-018-0571-z
- Lakshminarayanan, 2013, Efficient dendrimer–DNA complexation and gene delivery vector properties of nitrogen-core poly(propyl ether imine) dendrimer in mammalian cells, Bioconjug. Chem., 24, 1612, 10.1021/bc400247w · DOI
- Abel, 2012, Molecular dynamics simulations of a characteristic DPC micelle in water, J. Chem. Theory Comput., 8, 4610, 10.1021/ct3003207 · DOI
- Faramarzi, 2017, Molecular dynamics simulations as a tool for accurate determination of surfactant micelle properties, Langmuir, 33, 9934, 10.1021/acs.langmuir.7b02666 · DOI
- He, 2017, Simulation study of interaction mechanism between peptide and asymmetric membrane, Mol. Simul., 43, 34, 10.1080/08927022.2016.1228105 · doi:10.1080/08927022.2016.1228105
- Kmiecik, 2016, Coarse-grained protein models and their applications, Chem. Rev., 116, 7898, 10.1021/acs.chemrev.6b00163 · DOI · Paper page
- Tabujew, 2019, Tackling the limitations of copolymeric small interfering RNA delivery agents by a combined experimental–computational approach, Biomacromolecules, 20, 4389, 10.1021/acs.biomac.9b01061 · DOI
- Bruininks, 2020, A molecular view on the escape of lipoplexed DNA from the endosome, eLife, 9, 10.7554/eLife.52012 · DOI
- Wang, 1999, General solution for diffusion-controlled dissolution of spherical particles. 1. Theory, J. Pharm. Sci., 88, 731, 10.1021/js980236p · DOI · Paper page
- Kieckhefen, 2020, Possibilities and limits of computational fluid dynamics-discrete element method simulations in process engineering: a review of recent advancements and future trends, Annu. Rev. Chem. Biomol. Eng., 11, 397, 10.1146/annurev-chembioeng-110519-075414 · doi:10.1146/annurev-chembioeng-110519-075414
- Yeom, 2019, Application of the discrete element method for manufacturing process simulation in the pharmaceutical industry, Pharmaceutics, 11, 10.3390/pharmaceutics11080414 · DOI · Paper page
- Noyes, 1897, The Rate of Solution of Solid Substances in Their Own Solutions, J. Am. Chem. Soc., 19, 930, 10.1021/ja02086a003 · DOI · Paper page
- Peppas, 2014, Mathematical models in drug delivery: how modeling has shaped the way we design new drug delivery systems, J. Control. Release, 190, 75, 10.1016/j.jconrel.2014.06.041 · DOI · Paper page
- Siepmann, 2008, Mathematical modeling of drug delivery, Int. J. Pharm., 364, 328, 10.1016/j.ijpharm.2008.09.004 · DOI · Paper page
- Mircioiu, 2019, Mathematical modeling of release kinetics from supramolecular drug delivery systems, Pharmaceutics, 11, 10.3390/pharmaceutics11030140 · DOI · Paper page
- Grassi, 2014, Application of mathematical modeling in sustained release delivery systems, Expert. Opin. Drug Deliv., 11, 1299, 10.1517/17425247.2014.924497 · doi:10.1517/17425247.2014.924497
- Higuchi, 1961, Rate of release of medicaments from ointment bases containing drugs in suspension, J. Pharm. Sci., 50, 874, 10.1002/jps.2600501018 · DOI · Paper page
- Korsmeyer, R.W., Lustig, S.R., and Peppas, N.A., Solute and penetrant diffusion in swellable polymers. II. Verification of theoretical models. J. Polym. Sci. Polym. Phys. 24: p. 409–434. · DOI · Paper page
- Narasimhan, 1997, Molecular analysis of drug delivery systems controlled by dissolution of the polymer carrier, J. Pharm. Sci., 86, 297, 10.1021/js960372z · DOI · Paper page
- Siepmann, 2000, Hydrophilic matrices for controlled drug delivery: an improved mathematical model to predict the resulting drug release kinetics (the “sequential layer” model), Pharm. Res., 17, 1290, 10.1023/A:1026455822595 · DOI · Paper page
- Siepmann, 2002, A new mathematical model quantifying drug release from bioerodible microparticles using Monte Carlo simulations, Pharm. Res., 19, 1885, 10.1023/A:1021457911533 · DOI · Paper page
- Tzur-Balter, 2013, Mathematical modeling of drug release from nanostructured porous Si: combining carrier erosion and hindered drug diffusion for predicting release kinetics, Acta Biomater., 9, 8346, 10.1016/j.actbio.2013.06.007 · DOI
- Peppas, 1985, Analysis of Fickian and non-Fickian drug release from polymers, Pharm. Acta Helv., 60, 110
- Cooney, 1972, Effect of geometry on the dissolution of pharmaceutical tablets and other solids: Surface detachment kinetics controlling, AICHE J., 18, 446, 10.1002/aic.690180234 · DOI
- Delplace, 2019, Controlled release strategy designed for intravitreal protein delivery to the retina, J. Control. Release, 293, 10, 10.1016/j.jconrel.2018.11.012 · DOI
- Vulic, 2015, Mathematical model accurately predicts protein release from an affinity-based delivery system, J. Control. Release, 197, 69, 10.1016/j.jconrel.2014.10.032 · DOI
- Haghiralsadat, 2018, A comprehensive mathematical model of drug release kinetics from nano-liposomes, derived from optimization studies of cationic PEGylated liposomal doxorubicin formulations for drug-gene delivery, Artif. Cells Nanomed. Biotechnol., 46, 169, 10.1080/21691401.2017.1304403 · DOI
- Jakubiak, 2016, Development of a unified dissolution and precipitation model and its use for the prediction of oral drug absorption, Mol. Pharm., 13, 586, 10.1021/acs.molpharmaceut.5b00808 · DOI
- Bennema, 1977, Crystal growth from solution: development in computer simulation, J. Cryst. Growth, 42, 201, 10.1016/0022-0248(77)90196-8 · doi:10.1016/0022-0248(77)90196-8
- Baldan, 2002, Review Progress in Ostwald ripening theories and their applications to nickel-base superalloys Part I: Ostwald ripening theories, J. Mater. Sci., 37, 2171, 10.1023/A:1015388912729 · DOI · Paper page
- Penn, 1998, Imperfect oriented attachment: dislocation generation in defect-free nanocrystals, Science, 281, 969, 10.1126/science.281.5379.969 · DOI · Paper page
- Zhang, 2010, Progress of nanocrystalline growth kinetics based on oriented attachment, Nanoscale, 2, 18, 10.1039/B9NR00047J · DOI · Paper page
- Weiss, 1986, Overview of theoretical models for reaction rates, J. Stat. Phys., 42, 3, 10.1007/BF01010838 · doi:10.1007/bf01010838
- Ma, 2008, Crystal growth rate dispersion modeling using morphological population balance, AICHE J., 54, 2321, 10.1002/aic.11549 · doi:10.1002/aic.11549
- Rachah, 2016, A mathematical model for continuous crystallization, Math. Methods Appl. Sci., 39, 1101, 10.1002/mma.3553 · doi:10.1002/mma.3553
- Vetter, 2013, Modeling nucleation, growth, and Ostwald ripening in crystallization processes: a comparison between population balance and kinetic rate equation, Cryst. Growth Des., 13, 4890, 10.1021/cg4010714 · DOI
- Ma, 2018, Combining morphological population balances with face-specific growth kinetics data to model and predict the crystallization processes for ibuprofen, Ind. Eng. Chem. Res., 57, 16379, 10.1021/acs.iecr.8b02140 · DOI
- Gao, 2021, An integrated computational methodology with data-driven machine learning, molecular modeling and PBPK modeling to accelerate solid dispersion formulation design, Eur. J. Pharm. Biopharm., 158, 336, 10.1016/j.ejpb.2020.12.001 · DOI
- Grassi, 2000, Drug release from an ensemble of swellable crosslinked polymer particles, J. Control. Release, 68, 97, 10.1016/S0168-3659(00)00241-8 · DOI
- Andersen, 2019, A practical guide to surface kinetic Monte Carlo simulations, Front. Chem., 7, 10.3389/fchem.2019.00202 · DOI · Paper page
- Kremer, 2006, Process simulation in the pharmaceutical industry: a review of some basic physical models, J. Pharm. Sci., 95, 517, 10.1002/jps.20583 · DOI
- Jang, 2020, Model-based scale-up methodologies for pharmaceutical granulation, Pharmaceutics, 12, 10.3390/pharmaceutics12050453 · doi:10.3390/pharmaceutics12050453
- Khorasani, 2016, Process optimization of dry granulation based tableting line: Extracting physical material characteristics from granules, ribbons and tablets using near-IR (NIR) spectroscopic measurement, Powder Technol., 300, 120, 10.1016/j.powtec.2016.03.004 · doi:10.1016/j.powtec.2016.03.004
- Narang, 2017, Application of in-line focused beam reflectance measurement to brivanib alaninate wet granulation process to enable scale-up and attribute-based monitoring and control strategies, J. Pharm. Sci., 106, 224, 10.1016/j.xphs.2016.08.025 · doi:10.1016/j.xphs.2016.08.025
- Nagy, 2017, In-line Raman spectroscopic monitoring and feedback control of a continuous twin-screw pharmaceutical powder blending and tableting process, Int. J. Pharm., 530, 21, 10.1016/j.ijpharm.2017.07.041 · DOI
- Saleemi, 2012, Enhancing crystalline properties of a cardiovascular active pharmaceutical ingredient using a process analytical technology based crystallization feedback control strategy, Int. J. Pharm., 430, 56, 10.1016/j.ijpharm.2012.03.029 · DOI
- Kim, 2011, Application of internal seeding and temperature cycling for reduction of liquid inclusion in the crystallization of RDX, Org. Process. Res. Dev., 15, 602, 10.1021/op100334y · doi:10.1021/op100334y
- Vargas, 2018, Process analytical technology in continuous manufacturing of a commercial pharmaceutical product, Int. J. Pharm., 538, 167, 10.1016/j.ijpharm.2018.01.003 · DOI
- Babnik, 2020, A review of computational fluid dynamics (CFD) simulations of mixing in the pharmaceutical industry, Biomed. J. Sci. Tech. Res., 3, 20732
- Ding, 1990, A bubbling fluidization model using kinetic theory of granular flow, AICHE J., 36, 523, 10.1002/aic.690360404 · DOI · Paper page
- Mortier, 2011, Mechanistic modelling of fluidized bed drying processes of wet porous granules: a review, Eur. J. Pharm. Biopharm., 79, 205, 10.1016/j.ejpb.2011.05.013 · DOI
- Jamaleddine, 2010, Application of computational fluid dynamics for simulation of drying processes: a review, Dry. Technol., 28, 120, 10.1080/07373930903517458 · DOI · Paper page
- Alexeenko, 2009, Computational analysis of fluid dynamics in pharmaceutical freeze-drying, J. Pharm. Sci., 98, 3483, 10.1002/jps.21862 · DOI
- Barresi, 2018, Use of computational fluid dynamics for improving freeze-dryers design and process understanding. Part 1: modelling the lyophilisation chamber, Eur. J. Pharm. Biopharm., 129, 30, 10.1016/j.ejpb.2018.05.008 · doi:10.1016/j.ejpb.2018.05.008
- Marchisio, 2018, Use of computational fluid dynamics for improving freeze-dryers design and process understanding. Part 2: Condenser duct and valve modelling, Eur. J. Pharm. Biopharm., 129, 45, 10.1016/j.ejpb.2018.05.003 · doi:10.1016/j.ejpb.2018.05.003
- Zhang, 2002, Aerosol transport and deposition in a triple bifurcation bronchial airway model with local tumors, Inhal. Toxicol., 14, 1111, 10.1080/08958370290084809 · doi:10.1080/08958370290084809
- Mitsakou, 2005, Eulerian modelling of lung deposition with sectional representation of aerosol dynamics, J. Aerosol Sci., 36, 75, 10.1016/j.jaerosci.2004.08.008 · DOI
- Ruzycki, 2013, The use of computational fluid dynamics in inhaler design, Expert Opin. Drug Deliv., 10, 307, 10.1517/17425247.2013.753053 · doi:10.1517/17425247.2013.753053
- Das, 2018, Targeting inhaled aerosol delivery to upper airways in children: Insight from computational fluid dynamics (CFD), PLoS One, 13, 10.1371/journal.pone.0207711 · DOI
- Kannan, 2017, Pharmaceutical aerosols deposition patterns from a Dry Powder Inhaler: Euler Lagrangian prediction and validation, Med. Eng. Phys., 42, 35, 10.1016/j.medengphy.2016.11.007 · doi:10.1016/j.medengphy.2016.11.007
- Newman, 2000, Scintigraphic comparison of budesonide deposition from two dry powder inhalers, Eur. Respir. J., 16, 178, 10.1034/j.1399-3003.2000.16a29.x · doi:10.1034/j.1399-3003.2000.16a29.x
- Tian, 2015, Validating CFD predictions of pharmaceutical aerosol deposition with in vivo data, Pharm. Res., 32, 3170, 10.1007/s11095-015-1695-1 · DOI
- Zhu, 2007, Discrete particle simulation of particulate systems: theoretical developments, Chem. Eng. Sci., 62, 3378, 10.1016/j.ces.2006.12.089 · DOI · Paper page
- Zhang, 2020, Discrete element analysis of normal elastic impact of wet particles, Powder Technol., 362, 628, 10.1016/j.powtec.2019.12.021 · doi:10.1016/j.powtec.2019.12.021
- Liu, 2020, Migration and agglomeration of adhesive microparticle suspensions in a pressure-driven duct flow, AICHE J., 66, 10.1002/aic.16974 · doi:10.1002/aic.16974
- Capozzi, 2019, A multi-scale computational framework for modeling the freeze-drying of microparticles in packed-beds, Powder Technol., 343, 834, 10.1016/j.powtec.2018.11.067 · doi:10.1016/j.powtec.2018.11.067
- Jones, 2013, Basic concepts in physiologically based pharmacokinetic modeling in drug discovery and development, CPT Pharmacometrics Syst. Pharmacol., 2, 1, 10.1038/psp.2013.41 · DOI · Paper page
- Teorell, 1937, Kinetics of distribution of substances administered to the body, I: the extravascular modes of administration, Arch. Int. Pharmacodyn. Therapie, 57, 205
- Yu, 1996, Compartmental transit and dispersion model analysis of small intestinal transit flow in humans, Int. J. Pharm., 140, 111, 10.1016/0378-5173(96)04592-9 · DOI · Paper page
- Thelen, 2012, Evolution of a detailed physiological model to simulate the gastrointestinal transit and absorption process in humans, part II: Extension to describe performance of solid dosage forms, J. Pharm. Sci., 101, 1267, 10.1002/jps.22825 · DOI
- Winiwarter, 1998, Correlation of human jejunal permeability (in vivo) of drugs with experimentally and theoretically derived parameters. A multivariate data analysis approach, J. Med. Chem., 41, 4939, 10.1021/jm9810102 · DOI · Paper page
- Ghate, 2019, Physiologically based pharmacokinetic (PBPK) modelling for in vitro-in vivo extrapolation: emphasis on the use of dissolution data, Dissol. Technol., 26, 18, 10.14227/DT260319P18 · DOI
- Kostewicz, 2014, PBPK models for the prediction of in vivo performance of oral dosage forms, Eur. J. Pharm. Sci., 57, 300, 10.1016/j.ejps.2013.09.008 · DOI · Paper page
- Shah, 2013, Improved human bioavailability of vemurafenib, a practically insoluble drug, using an amorphous polymer-stabilized solid dispersion prepared by a solvent-controlled coprecipitation process, J. Pharm. Sci., 102, 967, 10.1002/jps.23425 · DOI · Paper page
- Kawabata, 2011, Formulation design for poorly water-soluble drugs based on biopharmaceutics classification system: basic approaches and practical applications, Int. J. Pharm., 420, 1, 10.1016/j.ijpharm.2011.08.032 · DOI · Paper page
- Thakore, 2019, Assessment of biopharmaceutical performance of supersaturating formulations of carbamazepine in rats using physiologically based pharmacokinetic modeling, AAPS PharmSciTech, 20, 10.1208/s12249-019-1386-z · doi:10.1208/s12249-019-1386-z
- Purohit, 2018, Investigating the impact of drug crystallinity in amorphous tacrolimus capsules on pharmacokinetics and bioequivalence using discriminatory in vitro dissolution testing and physiologically based pharmacokinetic modeling and simulation, J. Pharm. Sci., 107, 1330, 10.1016/j.xphs.2017.12.024 · doi:10.1016/j.xphs.2017.12.024
- Dahan, 2010, The solubility-permeability interplay in using cyclodextrins as pharmaceutical solubilizers: mechanistic modeling and application to progesterone, J. Pharm. Sci., 99, 2739, 10.1002/jps.22033 · DOI · Paper page
- Sun, 2018, The solubility-permeability trade-off of progesterone with cyclodextrins under physiological conditions: experimental observations and computer simulations, J. Pharm. Sci., 107, 488, 10.1016/j.xphs.2017.09.032 · doi:10.1016/j.xphs.2017.09.032
- Wang, 2021, Prediction of free drug absorption in cyclodextrin formulation by a modified physiologically based pharmacokinetic model and phase solubility 3-d surface graph, Pharm. Res., 10.1007/s11095-021-03071-3 · DOI
- Williams, 2013, Strategies to address low drug solubility in discovery and development, Pharmacol. Rev., 65, 315, 10.1124/pr.112.005660 · DOI · Paper page
- Rasenack, 2002, Dissolution rate enhancement by in situ micronization of poorly water-soluble drugs, Pharm. Res., 19, 1894, 10.1023/A:1021410028371 · DOI · Paper page
- Li, 2019, Justification of biowaiver and dissolution rate specifications for piroxicam immediate release products based on physiologically based pharmacokinetic modeling: an in-depth analysis, Mol. Pharm., 16, 3780, 10.1021/acs.molpharmaceut.9b00350 · DOI
- Zhang, 2014, Application of physiologically based absorption modeling to formulation development of a low solubility, low permeability weak base: Mechanistic investigation of food effect, AAPS PharmSciTech, 15, 400, 10.1208/s12249-014-0075-1 · DOI
- Litou, 2019, Combining biorelevant in vitro and in silico tools to simulate and better understand the in vivo performance of a nano-sized formulation of aprepitant in the fasted and fed states, Eur. J. Pharm. Sci., 138, 105031, 10.1016/j.ejps.2019.105031 · DOI
- Shono, 2010, Forecasting in vivo oral absorption and food effect of micronized and nanosized aprepitant formulations in humans, Eur. J. Pharm. Biopharm., 76, 95, 10.1016/j.ejpb.2010.05.009 · DOI
- Parrott, 2014, Physiologically based absorption modelling to predict the impact of drug properties on pharmacokinetics of bitopertin, AAPS J., 16, 1077, 10.1208/s12248-014-9639-y · DOI
- O'Shea, 2015, Lipidic dispersion to reduce food dependent oral bioavailability of fenofibrate: in vitro, in vivo and in silico assessments, Eur. J. Pharm. Biopharm., 96, 207, 10.1016/j.ejpb.2015.07.014 · DOI
- Emami Riedmaier, 2018, Mechanistic physiologically based pharmacokinetic modeling of the dissolution and food effect of a biopharmaceutics classification system IV compound—The Venetoclax story, J. Pharm. Sci., 107, 495, 10.1016/j.xphs.2017.09.027 · DOI
- Kambayashi, 2019, PBPK modeling coupled with biorelevant dissolution to forecast the oral performance of amorphous solid dispersion formulations, Eur. J. Pharm. Sci., 135, 83, 10.1016/j.ejps.2019.05.013 · DOI
- Hansmann, 2018, An in silico approach to determine challenges in the bioavailability of ciprofloxacin, a poorly soluble weak base with borderline solubility and permeability characteristics, Eur. J. Pharm. Biopharm., 122, 186, 10.1016/j.ejpb.2017.10.019 · DOI
- Xia, 2013, Utility of physiologically based modeling and preclinical in vitro/in vivo data to mitigate positive food effect in a BCS class 2 compound, AAPS PharmSciTech, 14, 1255, 10.1208/s12249-013-0018-2 · DOI
- Dong, 2015, Elucidating the in vivo fate of nanocrystals using a physiologically based pharmacokinetic model: a case study with the anticancer agent SNX-2112, Int. J. Nanomedicine, 10, 2521
- Yuan, 2019, Physiologically based pharmacokinetic modeling of nanoparticles, J. Pharm. Sci., 108, 58, 10.1016/j.xphs.2018.10.037 · DOI · Paper page
- Boger, 2019, Physiologically based pharmacokinetic/pharmacodynamic modeling accurately predicts the better bronchodilatory effect of inhaled versus oral salbutamol dosage forms, J. Aerosol. Med. Pulm Drug Deliv., 32, 1, 10.1089/jamp.2017.1436 · DOI
- Chen, 2016, In silico modelling of transdermal and systemic kinetics of topically applied solutes: model development and initial validation for transdermal nicotine, Pharm. Res., 33, 1602, 10.1007/s11095-016-1900-x · doi:10.1007/s11095-016-1900-x
- Le Merdy, 2019, Application of mechanistic ocular absorption modeling and simulation to understand the impact of formulation properties on ophthalmic bioavailability in rabbits: a case study using dexamethasone suspension, AAPS J., 21, 10.1208/s12248-019-0334-x · doi:10.1208/s12248-019-0334-x
- Continuous Symposium
- Steinwandter, 2019, Data science tools and applications on the way to Pharma 4.0, Drug Discov. Today, 24, 1795, 10.1016/j.drudis.2019.06.005 · DOI
- Afantitis, 2020, NanoSolveIT Project: Driving nanoinformatics research to develop innovative and integrated tools for in silico nanosafety assessment, Comput. Struct. Biotechnol. J., 18, 583, 10.1016/j.csbj.2020.02.023 · DOI
- Lu, 2021, Deep learning prediction of patient response time course from early data via neural-pharmacokinetic/pharmacodynamic modelling, Nat. Mach. Intell., 10.1038/s42256-021-00357-4 · DOI
- Noé, 2020, Machine learning for molecular simulation, Annu. Rev. Phys. Chem., 71, 361, 10.1146/annurev-physchem-042018-052331 · DOI · Paper page
- Chiang, 2017, Big data analytics in chemical engineering, Annu. Rev. Chem. Biomol. Eng., 8, 63, 10.1146/annurev-chembioeng-060816-101555 · DOI · Paper page
- David, 2001, Productivity growth prospects and the new economy in historical perspective, EIB Papers, 6, 41
- David, 1990, The dynamo and the computer an historical perspective on the modern productivity paradox, Am. Econ. Rev., 80, 355
- Temin, 2008, Private borrowing during the financial revolution: hoare's bank and its customers, 1702-24, Econ. Hist. Riv., 62, 541, 10.1111/j.1468-0289.2007.00420.x · DOI
Cited by
Emerging Applications of Nanotechnology in Healthcare and Medicine
Malik, S., Muhammad, K., & Waheed, Y. (2023) · Molecules · doi:10.3390/molecules28186624 · Cited by 610
Metadata
- Authors
- Wang, W., Ye, Z., Gao, H., & Ouyang, D.
- Venue
- Journal of Controlled Release
- Publisher
- Elsevier BV
- Published
- 2021-10
- Volume
- 338
- Pages
- 119-136
- ISSN
- 0168-3659 (ISSN-L)
- OpenAlex
- W3195421105
- Cited by
- 218
- References
- 14
- FWCI
- 16.00
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- doi.org/10.15223/policy-017 (stm-asf)
- doi.org/10.15223/policy-037 (stm-asf)
- doi.org/10.15223/policy-012 (stm-asf)
- doi.org/10.15223/policy-029 (stm-asf)
- doi.org/10.15223/policy-004 (stm-asf)
- Funders
- Universidade de Macau (MYRG2019-00041-ICMS)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Computational pharmaceutics - A new paradigm of drug delivery. https://app.cochat.ai/papers/10.1016/j.jconrel.2021.08.030
- The paper
- Wang, W., Ye, Z., Gao, H., & Ouyang, D. (2021). Computational pharmaceutics - A new paradigm of drug delivery. Journal of Controlled Release. https://doi.org/10.1016/j.jconrel.2021.08.030
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.